Based on the latest shareholder registry finalized in late March 2026, Hau Giang Pharmaceutical JSC (DHG) has reported a failure... Read more
Category: Uncategorized
Vietnam and AstraZeneca strengthen strategic partnership in life sciences
During an official working visit to the United Kingdom, a leadership delegation from Vietnam’s Ministry of Health conducted a site... Read more
Progress on updating the legal framework for food safety governance
In an effort to modernize state management, an intensive discussion was held to review core policy orientations for the proposed... Read more
Vietnam develops Advanced Quality Standards to internationalize hospital system
On the morning of March 27, 2026, in Ho Chi Minh City, the Ministry of Health held a consultation workshop... Read more
Sarepta shares surge on promising early RNAi data from Arrowhead pact
Sarepta Therapeutics saw its stock jump 25% on Wednesday, March 25, 2026, following the release of encouraging Phase 1/2 clinical... Read more
MSD spends $6.7bn to acquire Terns Pharmaceuticals in oncology reinforcement
On March 25, 2026, MSD (known as Merck & Co. in the US) announced a definitive agreement to buy cancer... Read more
Gilead to Acquire Ouro Medicines in $2.1B Deal to Advance “Immune Reset” Therapy
On March 23, 2026, Gilead Sciences announced a definitive agreement to acquire Ouro Medicines in a deal potentially worth $2.175... Read more
Bayer shares dip as activist investor offloads $380M stake
On March 24, 2026, Bayer’s stock experienced a brief decline following a significant divestment by Inclusive Capital Partners. The move... Read more
Takeda targets $1.3B in cost savings to bankroll future drug launches
On March 25, 2026, Japan’s largest pharmaceutical company, Takeda, unveiled a sweeping new restructuring initiative. The program aims to deliver... Read more









